New patent for Xellia Pharms drug VANCOMYCIN

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for VANCOMYCIN
Annual Drug Patent Expirations for VANCOMYCIN

Vancomycin is a drug marketed by Xellia Pharms Aps, Akorn, Fresenius Kabi Usa, Lupin Ltd, Orient Pharma Co Ltd, Strides Pharma, Watson Labs, Alkem Labs Ltd, Aspiro, Emcure Pharms Ltd, Eugia Pharma, Gland Pharma Ltd, Hainan Poly, Hainan Poly Pharm, Hikma, Hikma Pharms, Hospira, Hospira Inc, Knack, Meitheal, Mylan Labs Ltd, Pharm Assoc, Sagent Pharms, Sandoz, Sandoz Inc, Teva Pharms Usa, and Samson Medcl and, and is included in forty-nine NDAs. It is available from one supplier. There are five patents protecting this drug.

VANCOMYCIN drug price trends.

This drug has thirty-four patent family members in twenty-seven countries.

The generic ingredient in VANCOMYCIN is vancomycin hydrochloride. One supplier is listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top